What other stocks do shareholders of Lexaria Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Aurora Cannabis (ACBFF) , Organigram (OGI) , Cronos Group (CRON) , Aphria (APHQF) , CV Sciences (CVSI) , Auxly Cannabis Group (CBWTF) , iAnthus Capital (ITHUF) , Alibaba Group (BABA) and GW Pharmaceuticals (GWPH) .

How do I buy shares of Lexaria Bioscience?

Shares of LXRP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:LXRP

Lexaria Bioscience (LXRP) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

Free LXRP Stock Alerts

Compare

Today's Range: N/A
50-Day Range: $0.22
▼
$0.22
52-Week Range: N/A

Volume: 2.15 million shs
Average Volume: 608,350 shs
Market Capitalization: $20.15 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Lexaria Bioscience alerts:

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Lexaria Bioscience Stock (OTCMKTS:LXRP)

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

>> Register right here

LXRP Stock News Headlines

April 16, 2024 | msn.com

Lexaria gets ethics board okay for oral GLP-1 study

March 27, 2024 | theglobeandmail.com

Lexaria (NASDAQ: LEXX) Hires Research Organization to Perform GLP-1 Human Pilot Study

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 14, 2024 | msn.com

Lexaria appoints Nelson Cabatuan as CFO

March 11, 2024 | theglobeandmail.com

Lexaria Bioscience (NASDAQ: LEXX) Banking on DehydraTECH(TM) for Major 2024 Growth

February 16, 2024 | finanznachrichten.de

Lexaria Bioscience Corp.: Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

February 15, 2024 | msn.com

Why Lexaria Bioscience (LEXX) Shares Are Moving

January 16, 2024 | finance.yahoo.com

Lexaria Unveils Extensive Planned 2024 GLP-1 Study Program

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

January 11, 2024 | finance.yahoo.com

Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream

November 30, 2023 | msn.com

LEXX: GLP-1s’ Sweet Opportunity

November 1, 2023 | finance.yahoo.com

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space

October 18, 2023 | markets.businessinsider.com

Lexaria Bioscience’s Growth Prospects: New Licensing Agreement, Advanced Core Pipeline, and Positive Clinical Trials

October 13, 2023 | finance.yahoo.com

Lexaria Enters New Global Exclusive Collaboration and License Agreement with SulfoSyn

August 5, 2023 | msn.com

Lexaria Bioscience (NASDAQ: LEXX) Expands Portfolio in Oral Nicotine Delivery Sector

August 2, 2023 | finanznachrichten.de

Lexaria Bioscience Corp.: Lexaria's Plans to Study Weight Loss and Diabetes Control in a Human Clinical Study with DehydraTECH-CBD

July 29, 2023 | theglobeandmail.com

Lexaria Bioscience (NASDAQ: LEXX, LEXXW) Announces New Subsidiary, Provides Update on Nicotine Study

July 28, 2023 | finanznachrichten.de

Lexaria Bioscience Corp.: Lexaria Incorporates New Subsidiary for CPG Products and Updates Human Nicotine Study

July 28, 2023 | finance.yahoo.com

Lexaria Incorporates New Subsidiary for CPG Products and Updates Human Nicotine Study

July 19, 2023 | finanznachrichten.de

Lexaria Bioscience Corp.: Lexaria Granted Strategically Important New US Patent For DehydraTECH-Nicotine Including Oral Pouch Products

May 10, 2023 | finanznachrichten.de

Lexaria Bioscience Corp.: Lexaria Announces 2023 Annual Meeting Results

May 10, 2023 | finance.yahoo.com

Lexaria Announces 2023 Annual Meeting Results

May 9, 2023 | theglobeandmail.com

Lexaria Bioscience (NASDAQ: LEXX) Announces Dosing Completed on Human Nicotine Study

May 9, 2023 | investorplace.com

Why Is Lexaria Bioscience (LEXX) Stock Down 27% Today?

May 8, 2023 | finanznachrichten.de

Lexaria Bioscience Corp.: Lexaria's Human Clinical Nicotine Study Completes Dosing as Planned

May 8, 2023 | finance.yahoo.com

Lexaria’s Human Clinical Nicotine Study Completes Dosing as Planned

April 25, 2023 | finanznachrichten.de

Lexaria Bioscience Corp.: Lexaria Awards CRO Contract for Upcoming U.S. Phase 1b Hypertension Study

See More Headlines

Receive LXRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Metal Mining
Sub-Industry: N/A
Current Symbol: OTCMKTS:LXRP
CUSIP: 52886N208
CIK: 1348362
Web: www.lexariabioscience.com
Phone: (250) 765-6424
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,090,000.00
Net Margins: -1,046.77%
Pretax Margin: N/A
Return on Equity: -157.62%
Return on Assets: -148.09%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 8.52
Quick Ratio: 8.01

Sales & Book Value

Annual Sales: $380,000.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.03 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 89,587,000
Free Float: N/A
Market Cap: $20.15 million
Optionable: Not Optionable
Beta: N/A

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Christopher A. Bunka (Age 58)
Chairman & CEO
Comp: $300.8k
Mr. John M. Docherty (Age 51)
Pres & Director
Comp: $242.52k
Mr. Allan Spissinger C.A. (Age 51)
CPA, CFO, Corp. Sec. & Treasurer
Comp: $121.66k
Vanessa Carle
Head of Legal
Dr. Philip Ainslie
Advisor & Consultant

Key Competitors

View All Competitors

LXRP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Lexaria Bioscience own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Aurora Cannabis (ACBFF), Organigram (OGI), Cronos Group (CRON), Aphria (APHQF), CV Sciences (CVSI), Auxly Cannabis Group (CBWTF), iAnthus Capital (ITHUF), Alibaba Group (BABA) and GW Pharmaceuticals (GWPH).
How do I buy shares of Lexaria Bioscience?: Shares of LXRP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LXRP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Lexaria Bioscience (LXRP) Stock Price, News & Analysis

About Lexaria Bioscience Stock (OTCMKTS:LXRP)

LXRP Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

LXRP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info